33 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
additional capital;
risks and uncertainties associated with shutdowns or delays caused by the COVID-19 pandemic; and
other factors beyond the Company’s
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
and assess the impact COVID-19 will have on its business activities. The extent of the effect of COVID-19 pandemic on the Company is uncertain
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
capital;
risks and uncertainties associated with shutdowns or delays caused by the COVID-19 pandemic; and
other factors beyond the Company’s control
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
28 Jul 22
Current report (foreign)
2:52pm
NEWS RELEASE
RepliCel’s Manufacturing Inspected by Japan’s PMDA
After over a year of pandemic-related delays, representatives of Japan’s PMDA
6-K
EX-99.4
ytoovp90 p2x
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
dvgr7
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
xloc 7k6i0bey
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
0w1148 q16
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
s2wgbxit0mnhn c7h1
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.5
qx55w1l2dnz7y pc543
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
blee8jf12 2iik
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
fkyexu8nyr
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.3
5aeap pf06a79u
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
w3m7iil
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
gxgwwmq57vwl
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm